Log in to your Inderes Free account to see all free content on this page.
Bioretec
0.03 EUR
-5.41 %
1,734 following
Corporate customer
BRETEC
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
Valuation
Income statement
Quarterly estimates
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Bioretec
EV/S
Median 2021-2025
Dividend yield
Median 2021-2025
P/B
Median 2021-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price (EUR) | 2.70 | 1.40 | 2.18 | 2.40 | 0.60 | 0.03 | 0.03 | 0.03 | 0.03 | ||
| Shares | 144.9 | 150.4 | 14.1 | 14.1 | 19.1 | 23.3 | 30.8 | 1,508.6 | 1,508.6 | 1,508.6 | 1,508.6 |
| Market cap | 38.1 | 19.8 | 41.7 | 56.0 | 18.5 | 42.2 | 42.2 | 42.2 | 42.2 | ||
| Enterprise value | 33.5 | 20.1 | 37.2 | 51.2 | 16.3 | 34.1 | 41.2 | 43.1 | 43.0 | ||
| EV/S | - | - | 16.7 | 6.8 | 9.5 | 11.3 | 4.6 | 7.5 | 5.2 | 3.9 | 2.8 |
| EV/EBITDA | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | neg. | 24.5 |
| EV/EBIT (adj.) | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | neg. | 34.6 |
| EV/EBIT | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | neg. | 34.6 |
| P/E (adj.) | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | neg. | 63.3 |
| P/E | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | neg. | 63.3 |
| P/B | - | - | 8.8 | 10.3 | 5.1 | 5.8 | 1.9 | 2.7 | 4.9 | 5.7 | 5.2 |
| P/S | - | - | 19.0 | 6.7 | 10.7 | 12.3 | 5.2 | 9.3 | 5.3 | 3.8 | 2.7 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | ||
| Equity ratio | -77.2 % | 35.0 % | 50.3 % | 55.0 % | 77.2 % | 84.8 % | 83.6 % | 95.7 % | 92.5 % | 82.8 % | 84.3 % |
| Gearing ratio | -162.2 % | -16.2 % | -107.1 % | 17.9 % | -54.5 % | -49.5 % | -22.6 % | -52.2 % | -12.4 % | 11.7 % | 9.1 % |
Login required
This content is only available for logged in users